New cancerostatics developed in Czechoslovakia. Introductory lecture.
D000179:Acrylates / Q000494:pharmacology; D000477:Alkylating Agents / Q000138:chemical synthesis / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology; D001966:Bromine / Q000494:pharmacology; D003562:Cytidine / Q000494:pharmacology; D005461:Fluorine / Q000494:pharmacology; D006801:Humans; D007042:Hypoxanthines / Q000494:pharmacology; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D013843:Thiazines / Q000494:pharmacology; D014498:Uracil / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000494:pharmacology; D014631:Valerates / Q000494:pharmacology
D000179:Acrylates; D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D001565:Benzoates; D007042:Hypoxanthines; D009588:Nitrogen Mustard Compounds; D011743:Pyrimidines; D013843:Thiazines; D014631:Valerates; D005461:Fluorine; D014498:Uracil; D003562:Cytidine; D001966:Bromine